Hyperglycemia is believed to be the major cause of diabetic vascular complications involving both microvessels and arteries as in the retina, renal glomeruli, and aorta. It is unclear by which mechanism hyperglycemia is altering the metabolism and functions of vascular cells, although changes in nonenzymatic protein glycosylation and increases in cellular sorbitol levels have been postulated to be involved. Previously, we have reported that the elevation of extracellular glucose levels with cultured bovine retinal capillary endothelial cells causes an increase in protein kinase C (PKC) activity of the membranous pool with a parallel decrease in the cytosol without alteration of its total activity. Now we demonstrate that the mechanism for the activation of PKC is due to an enhanced de novo synthesis of diacylglycerol as indicated by a 2-fold increase of ['4Cldiacylglycerol labeling from [14C]glucose. The elevated diacylglycerol de novo synthesis is secondarily due to increased formation of precursors derived from glucose metabolism; this formation is enhanced by hyperglycemia as substantiated by elevated [3H1glucose conversion into water. This effect of hyperglycemia on PKC is also observed in cultured aortic smooth muscle and endothelial cells and the retina and kidney of diabetic rats, but not in the brain. Since PKC in vascular cells has been shown to modulate hormone receptor turnover, neovascularization in vitro, and cell growth, we propose that this mechanism of enhancing the membranous PKC activities by hyperglycemia plays an important role in the development of diabetic vascular complications.Hyperglycemia is probably an important etiologic factor in the development of vascular complications in diabetic patients, such as retinopathy (1), nephropathy (2), and accelerated atherosclerosis (3). Nonenzymatic glycosylation (4,5) of protein and accumulation of intracellular sorbitol with reduction of myo-inositol levels (6, 7) have been proposed to be involved in the development of these vascular changes.Protein kinase C (PKC), the Ca2+/phospholipid-dependent protein kinase, appears to be involved in a variety of cellular functions such as signal transduction of cellular responses to hormones, growth factors, neurotransmitters, and drugs (8, 9). In vascular cells, PKC has been shown to modulate growth rate (10), DNA synthesis (11), hormone and growth factor receptor turnover (12), smooth muscle contraction (13-17), and cAMP responses to different hormones (18,19) and to stimulate neovascularization in vitro. Using cultured bovine retinal capillary endothelial cells, a cell type prominently involved in diabetic retinopathy (21), we have previously reported that the membranous pool of PKC activity was increased 100% by elevation of glucose level (22) but not by adding mannitol to the medium. This effect appears to be mostly an increase in the translocation of PKC from cytosol to the membrane since the total PKC activity is not altered and the maximally stimulated membranous PKC activities by phorbol 12...